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PURPOSE. Mutations in ZEB1 have been reported in posterior polymorphous corneal dystrophy
(PPCD3; MIM #609141) and Fuchs’ endothelial corneal dystrophy (FECD6; MIM #613270).
Although PPCD and keratoconus are clinically and pathologically distinct, PPCD has been
associated with keratoconus, suggesting a common genetic basis. The purpose of our study
was to perform mutational screening of the ZEB1 gene in patients affected with keratoconus
or PPCD.
METHODS. Sanger sequencing of ZEB1 was performed in 70 unrelated patients with
keratoconus and 18 unrelated patients with PPCD. Real-time quantitative PCR (RT-qPCR)
was performed on RNA from cultured corneal keratocytes obtained from a keratoconic
patient harboring a missense ZEB1 mutation (p.Gln640His) undergoing corneal transplan-
tation.
RESULTS. Mutational analysis of ZEB1 in PPCD identified a previously reported frameshift
mutation (c.1578_1579insG) and a novel nonsense mutation (c.2249C > A) in exon 7 of
ZEB1 causing the insertion of a stop codon: p.Ser750X. In the keratoconus cohort, a novel
heterozygous pathogenic mutation in exon 7 (c.1920G > T; p.Gln640His) of ZEB1 was
identified in a family affected with keratoconus and Fuchs’ endothelial corneal dystrophy. RT-
qPCR performed on cultured corneal keratocytes harboring the missense ZEB1 mutation
(p.Gln640His) demonstrated that COL4A1 and COL4A2 were markedly downregulated, and
COL4A3, COL4A4, and COL8A2 were moderately downregulated.
CONCLUSIONS. Our data combined with the previously reported mutational spectrum of ZEB1
support a genotype–phenotype correlation: missense substitutions in the ZEB1 protein are
associated with FECD6 and keratoconus, whereas protein truncating ZEB1 mutations result
in PPCD3. The dysregulation of a-type IV collagens represents a common link between ZEB1
mutation and the clinical phenotypes (PPCD3, FECD, and keratoconus).
Keywords: keratoconus, posterior polymorphous corneal dystrophy, Fuchs’ endothelial
dystrophy, ZEB1, corneal dystrophies, hereditary
The corneal dystrophies represent a group of inheritedcorneal disorders that are genetically and phenotypically
heterogeneous, and have been classified by phenotypic
description, pathologic examination, and genetic analysis.1
Posterior polymorphous corneal dystrophy (PPCD) is a rare
autosomal dominant disorder of the corneal endothelium1 that
shows highly variable expressivity in age of presentation and
clinical severity.2–4 Clinically, PPCD is characterized by the
presence of vesicles, bands, and geographic opacities involving
the endothelium and Descemet’s membrane.2,3 The inter- and
intrafamilial phenotypic spectrum of PPCD is wide, with some
patients remaining asymptomatic with a nonprogressive
course, while others show severe progressive disease develop-
ing visual impairment due to corneal edema and requiring
corneal transplantation.2,4–6
PPCD has been mapped to three different genetic loci,5,7,8
and there is evidence of further genetic heterogeneity.9–11
PPCD1 (MIM 605020) was mapped to chromosome 20p11.2-
q11.2, and mutations were reported in visual system homeobox
gene 1 (VSX1; MIM 605020) in PPCD and keratoconus (KTCN1;
MIM 148300).12 PPCD2 (MIM 609140) results from mutations
in COL8A2 encoding the alpha 2 chain of type VIII collagen
(MIM 120252), located on chromosome 1p34.3-p32.38. Muta-
tions in COL8A2 also have been reported in Fuchs’ endothelial
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corneal dystrophy (FECD1; MIM 136800).13 PPCD3 (MIM
609141) was mapped to chromosome 10p11.2 and mutations
were detected in zinc finger E box-binding homeobox 1 (ZEB1;
MIM 189909) which also is known as transcription factor 8
(TCF8) by some investigators.5,11 Mutations in ZEB1 account
for PPCD3 in approximately 30% of PPCD patients,5,9–11 and all
the reported ZEB1 mutations responsible for PPCD3 are
truncating.5,9–11 Missense mutations in ZEB1 have also been
reported in Fuchs’ endothelial corneal dystrophy (FECD6, MIM
613270).14,15
Although PPCD, Fuchs’ endothelial dystrophy, and kerato-
conus are clinically and pathologically distinct, keratoconus
has been associated with PPCD12,16–20 and Fuchs’ endothelial
dystrophy,16 suggesting a common link.12,17–21 Here, we report
the results of ZEB1 sequencing in a cohort of patients with
keratoconus and PPCD. Our data combined with the previous-
ly reported mutational spectrum of ZEB1 supports a geno-
type–phenotype correlation, in which protein truncating ZEB1
mutations result in PPCD, and missense substitutions in the
ZEB1 protein are associated with keratoconus and Fuchs’
endothelial dystrophy.
METHODS
Clinical Assessment
Patients affected with either keratoconus or posterior poly-
morphous corneal dystrophy were recruited as part of ongoing
studies from Belfast (Belfast Health and Social Care Trust,
Belfast, UK), Bristol (Bristol Eye Hospital, Bristol, UK), and
Toronto (Department of Ophthalmology and Vision Sciences,
The Hospital for Sick Children, University of Toronto, Toronto,
Ontario, Canada). A total of 96 unrelated individuals (192
chromosomes) without ocular disease (aged 60 and over) was
used as normal controls. All studies adhered to the tenets of the
Declaration of Helsinki, and were approved by the relevant
institutions with all participants giving written informed
consent. In subjects with pathogenic sequence variants a
medical history was taken to identify nonocular features
previously associated with ZEB1: inguinal hernias, hydroceles,
Dupuytren’s contractures, bony lumps, spinal disease, otoscle-
rosis, and Osgood-Schlatter disease.5,11
Patients were diagnosed with PPCD if they exhibited the
characteristic endothelial changes in both eyes (vesicles,
bands, or geographic opacities in the endothelium) on slit-
lamp biomicroscopy. The diagnosis of keratoconus was based
on well-established clinical signs on slit-lamp biomicroscopy
and cycloplegic retinoscopy, and a confirmatory videokerato-
graphic map.22,23 Videokeratographic evaluation was per-
formed on each eye using the Topographic Modelling System-
1 (Computed Anatomy, Inc., New York, NY), Orbscan II
(Bausch & Lomb, Salt Lake City, UT), or the Pentacam (Oculus,
Wetzlar, Germany). When determining the familial segregation
of ZEB1 sequence variants, all available family members
underwent clinical and topographic examination to determine
their clinical status and were screened molecularly.
DNA Extraction and Sequencing
Genomic DNA was extracted from peripheral blood leukocytes
using a Wizard Genomic DNA Purification Kit (Promega,
Southampton, UK) according to the manufacturer’s instruc-
tions. PCR primers for amplification and sequencing of the
exons, flanking intron sequences, and 50 and 30 untranslated
regions (UTR) of ZEB1 were identical to those described by
Krafchak et al.5 with adapted conditions, except for two
additional primers for sequencing that were designed using
Primer3 (v. 0.4.0) software (available in the public domain at
http://frodo.wi.mit.edu/primer3/)24 and are listed in Supple-
mentary Table S1. Bidirectional cycle sequencing was per-
formed using BigDye Terminator v3.1 cycle sequencing kit
(Applied Biosystems, Warrington, UK) and electrophoresed on
an ABI PRISM 3730 DNA sequencer (Applied Biosystems,
Warrington, UK). Sequencing results were analyzed manually
using the sequence analysis software SeqScape 2.1.1 (Applied
Biosystems). Identified sequence variants were described
according to the guidelines published by the Human Genome
Variation Society. Variants were annotated in accordance with
NCBI NM_030751.5. (Build GRCh37/hg19).
Deleterious structural effects of amino acid substitutions on
protein function were assessed using the PolyPhen-2 (Poly-
morphism Phenotyping v2; available in the public domain at
http://genetics.bwh.harvard.edu/pph2/),25 Sorting Intolerant
from Tolerant (SIFT; available in the public domain at http://
sift.jcvi.org/),26 and Pathological Mutations (PMut; available in
the public domain at http://mmb2.pcb.ub.es:8080/PMut/)27
algorithms. The conservation of the affected amino acid across
species was analyzed using Homologene (available in the
public domain at http://www.ncbi.nlm.nih.gov/homologene/)
and multiple sequence alignment using the UCSC Genome
Browser (available in the public domain at http://genome.ucsc.
edu/). ZEB1 sequence variants that were absent from controls
were assessed to determine potential effects on splicing using
Human Splicing Finder Version 2.4.1 (available in the public
domain at http://www.umd.be/HSF/).28
Human Corneal Keratocyte Cell Culture
Human corneal keratocytes were cultured directly from
residual normal donor corneoscleral rims (n ¼ 4) and from
corneal tissue obtained from a patient harboring a missense
mutation in ZEB1 (c.1920G > T; p.Gln640His) undergoing
corneal transplantation. Corneal stromal tissue was dissected,
fragmented, and plated on 60 mm Petri dishes. The cells were
maintained separately in Dulbecco’s modified Eagle’s medium/
nutrient Ham’s F-12 (1:1) medium (Gibco; Invitrogen Ltd.,
Paisley, UK) supplemented with 10% fetal calf serum (FCS) and
penicillin/streptomycin mix (1:1) (Sigma-Aldrich Company
Ltd., Dorset, UK), at 378C in a 5% CO2 incubator (MiniGalaxy
A C&M Scientific; Scientific Laboratory Supplies Ltd., Notting-
ham, UK). The phenotype of the cells was assessed on the
basis of the distinctive morphology of human corneal
keratocytes and positive vimentin (DAKO; DAKO Denmark A/
S, Glostrup, Denmark), and CD34 (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA) immunofluorescence staining. The
cultured cells also were negative for cytokeratin 3 (Millipore,
Billerica, MA) immunofluorescence indicating an absence of
corneal epithelial cell contamination. Cells were cultured until
90% confluence (10–14 days) and total RNA was extracted
using the TRI Reagent (Sigma-Aldrich Company, Ltd.) and
quantified on the Nanodrop-1000 (Nanodrop Technologies,
Wilmington, DE). RNA quality was determined with the
Bioanalyzer (Agilent Technologies UK Limited, Cheshire, UK).
Real-Time Quantitative PCR (RT-qPCR)
Total RNA (1 lg) isolated from human corneal keratocytes was
reverse transcribed into cDNA using the QuantiTect Reverse
Transcription Kit (Qiagen, West Sussex, UK) according to
manufacturer’s protocol. RT-qPCR was performed by using a
real-time PCR system (LightCycler 480; Roche Diagnostics,
Basel, Switzerland). Primer sequences were obtained from
PrimerBank (available in the public domain at http://pga.mgh.
harvard.edu/primerbank/)29 for COL4A1, COL4A2, COL4A3,
COL4A4, COL4A5, COL4A6, COL8A2, and ZEB1. Real-time
PCR reactions were performed in 10 lL final volume
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containing 10 ng of cDNA, gene-specific primers, and
fluorescent dye SYBR green I (Fermentas UK Ltd., Cambridge,
UK; conditions available on request). All PCR reactions were
performed in technical triplicates. All mRNA levels were
measured as CT threshold levels and were normalized with
five reference genes30; glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH), peptidylprolyl isomerise A (PPIA), ubiquitin C
(UBC), hypoxanthine quinine phosphoribosyl transferase 1
(HPRT1), and ribosomal protein L5 (RPL5) CT values. Values
were expressed as fold increase over the corresponding values
for control by the 2-DDCT method. The DCt validation
experiments showed similar amplification efficiency for all
templates used (difference between linear slopes for all
templates less than 0.1). Three independent experiments were
performed and the average (6 SEM) results were calculated
using GraphPad software (GraphPad Software, San Diego, CA).
Data were expressed as the mean values 6 SEM and analyzed
using Student’s t-test. Statistical differences in the mean were
considered statistically significant at P < 0.05.
RESULTS
Sanger sequencing of the entire coding region of ZEB1 (exons
1–9) was performed on 70 unrelated patients with keratoconus
(27 familial and 43 sporadic cases) and 18 unrelated patients
with PPCD (7 familial and 11 sporadic cases). Pathogenicity of
identified sequence variants was determined by filtering using
the in-house sequencing data from 96 control subjects, data
from dbSNP (Build 137), the May 2012 release of the 1000
Genomes (1 KG) Project (available in the public domain at
http://browser.1000genomes.org/index.html), and the Exome
Variant Server (EVS), NHLBI Exome Sequencing Project (ESP;
Seattle, WA, available in the public domain at http://evs.gs.
washington.edu/EVS/), segregation in familial cases, residue
conservation, splicing analysis, and structural modeling.
Mutational Analysis of ZEB1 in PPCD
In unrelated patients with PPCD (n ¼ 18), we identified a
previously reported frameshift mutation c.1578_1579insG
(p.Val526fsX2)5 and a novel nonsense mutation (c.2249C >
A) in exon 7 of ZEB1 causing the insertion of a stop codon
(p.Ser750X) (Table 1, Fig. 1C). The sequence variant (c.2249C
> A; p.Ser750X) was considered pathogenic as it was not seen
in 192 control chromosomes or the 1KG and ESP data; and
segregated with the disease phenotype in all available family
members (6 affected and 2 unaffected individuals, Fig. 1A). The
p.Ser750X mutation would result in a premature termination of
ZEB1 resulting in the loss of the repression domain, the second
zinc finger cluster, and the acidic activation domain. The
clinical features of the family affected with PPCD resulting
from the ZEB1 p.Ser750X mutation are described in Figure 1B
and Supplementary Table S2.
The prev ious ly repor ted f rameshi f t muta t ion
c.1578_1579insG (p.Val526fsX2)5 was detected in a mother
and son from North America. The mutation segregated in the
family and was not seen in the unaffected father. The proband
was a 40-year-old woman with bilateral vesicles and endothelial
corneal changes. Her best corrected visual acuity was of 20/25
(right eye) and 20/20 (left eye) with corrective lenses: 2.50
diopters sphere (DS)/0.75 diopter cylinder (DC) at 1058 (right
eye) and 2.00 DS/1.25 DC at 768 (left eye). Her son had
normal unaided visual acuity (20/20) with a few scattered
corneal endothelial vesicles. Neither patient had extraocular
features reported with ZEB1 mutation, but the proband’s son
had undergone Achilles tendon lengthening for his spastic
diplegia resulting from cerebral palsy.
Mutational Analysis of ZEB1 in Keratoconus
In patients with keratoconus, we identified 7 heterozygous
sequence variants; 3 nonsynonymous and 4 synonymous
(Table 2). Three of these were known SNPs (rs80194531,
rs7918614, and rs35238902) and one was a novel SNP
(c.3177A > T; p.Pro1059Pro) seen in 5% (5/96) of controls,
although absent from the 1KG and EVS datasets. There were 3
novel heterozygous sequence variants (c.1574G > A: p.Gly525-
Glu, c.1920G > T: p.Gln640His, and c.2673G > C: p.Pro891-
Pro), which were absent from controls (192 chromosomes),
and the 1KG and ESP datasets.
The novel heterozygous sequence variant exon 7, c.1574G
> A (p.Gly525Glu), was identified in a patient with sporadic
keratoconus. This sequence variant results in a nonconserva-
tive substitution of a nonpolar neutral amino acid (glycine)
with a polar negatively charged hydrophilic residue (glutamic
acid). The glycine at position 525 is well conserved in
primates, although in the chicken and shrew the residue is a
glutamic acid. PMut predicted that the variant was pathologic
with a score of 0.8 and high reliability, whereas PolyPhen-2 and
SIFT predicted this substitution was benign and tolerated,
respectively. Given this evidence, we proposed that p.Gly525-
Glu is classified as potentially pathogenic. As the novel
synonymous change c.2673G > C (p.Pro891Pro) was absent
from controls, and the 1KG and ESP datasets, we sought to
determine whether there was an impact on splicing due to the
impact of the nucleotide substitution on exonic splicing
enhancers (ESE) and silencers (ESS).31 On ESE analysis the
nucleotide change c.2673G > C alters the predicted ESE
binding site, but we were unable to obtain RNA from the
patient to assess whether this nucleotide change results in
aberrant ZEB1 splicing.
The novel heterozygous pathogenic mutation in exon 7,
c.1920G > T (p.Gln640His), was identified in two siblings
with keratoconus (Fig. 2B). The nucleotide change causes the
conserved polar amino acid glutamine to be substituted by
the positively charged, basic amino acid histidine. The
glutamine at position 640 is the last amino acid of the
homeodomain, and is well conserved across primates and
other vertebrates as demonstrated in Figure 2C. SIFT analysis
predicted that the variant was damaging, whereas PolyPhen-2
and PMut predicted this substitution was benign and neutral,
respectively.
TABLE 1. ZEB1 Sequence Variants Identified in the Posterior Polymorphous Corneal Dystrophy Patient Cohort
Nucleotide
Position
Amino Acid
Change Exon/Intron Cases Controls dbSNP rs # 1KG (MAF %) ESP (MAF %) Classification
c.192C > T p.Asp64Asp Exon 2 2/18 0/96 rs7918614 Yes (6.7) Yes (6.4) Polymorphism
c.260-136T > C NA Intron 2 1/18 1/96 rs2839663 Yes (1.0) No Polymorphism
c.1578_1579insG p.Val526fsX2 Exon 7 Familial PPCD 0/96 NA No No Pathogenic mutation
c.2061A > C p.Pro687Pro Exon 7 2/18 0/96 rs34846414 Yes (1.9) Yes (1.94) Polymorphism
c.2249C > A p.Ser750X Exon 7 Familial PPCD 0/96 NA No No Pathogenic mutation
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FIGURE 1. (A) Segregation analysis of the c.2249C > A, p.Ser750X ZEB1 mutation in a UK family affected by PPCD. (B) Slit-lamp examination of
individual II:2 showed corneal endothelial vesicles seen typically in PPCD. (C) Sequence chromatogram showing the heterozygous c.2249C > A,
p.Ser750X mutation in exon 7 of ZEB1 identified in the family affected by PPCD. FP, forward primer; RP, reverse primer. (D) Pentacam corneal
topography images of right (OD) and left (OS) eyes of the proband (individual II:2). The upper maps show corneal steepening with regular astigmatism,
but no signs of keratoconus. The lower maps show a general increase in corneal thickness (central corneal thickness 651 lm associated with PPCD).
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TABLE 2. ZEB1 Sequence Variants Identified in the Keratoconus Patient Cohort
Nucleotide
Position
Amino Acid
Change
Exon/
Intron Cases Controls dbSNP rs# 1KG (MAF %) EVS (MAF %) Classification
c.192C > T p.Asp64Asp Exon 2 1/70 0/96 rs7918614 Yes (6.7) Yes (6.43) Polymorphism
c.233A > C p.Asn78Thr Exon 2 2/70* 0/96 rs80194531 Yes (1.2) Yes (1.68) Polymorphism
c.1257G > A p.Ala419Ala Exon 7 1/70 0/96 rs35238902 Yes (1.2) Yes (1.95) Polymorphism
c.1574G > A p.Gly525Glu Exon 7 1/70 0/96 NA No No Potentially pathogenic
c.1920G > T p.Gln640His Exon 7 Familial keratoconus
and FECD
0/96 NA No No Pathogenic mutation
c.2673G > C p.Pro891Pro Exon 8 1/70 0/96 NA No No Potentially pathogenic
c.3177A > T p.Pro1059Pro Exon 9 3/70 5/96 NA No No Polymorphism
* Patients were African American and sequencing of ZEB1 in ethnically matched controls detected this variant in 3/23 controls.
FIGURE 2. (A) Segregation analysis of the c.1920G > T, p.Gln640His ZEB1 mutation in the family affected by keratoconus (siblings) and Fuchs’
endothelial corneal dystrophy (mother). (B) Sequence chromatogram showing the heterozygous c.1920G > T, p.Gln640His mutation in exon 7 of
ZEB1. (C) Multiple sequence alignment showing highly conserved glutamine at position 640 in exon 7 of ZEB1.
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FIGURE 3. (A) Pentacam corneal topography images of right (OD) and left (OS) eyes of the proband (individual II:1; Fig. 2). The upper maps show
inferior corneal steepening with a maximal corneal power of 56.6 D (OD) and 59.1 D (OS) associated with corneal thinning (bottom maps)
confirming keratoconus. (B) Pentacam corneal topography corneal thickness maps of the mother of the proband (individual I:2; Fig. 2). The maps
show a general increase in corneal thickness especially in the right eye (OD) associated with corneal endothelial pump failure and corneal hydration
associated with FECD.
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Clinical Phenotype of Family With p.Gln640His
ZEB1 Mutation
The proband harboring the p.Gln640His mutation was a 39–
year-old Caucasian male (individual II:1, Fig. 2A) with bilateral
keratoconus. He was diagnosed at age 25 and commenced
contact lens wear at age 30. His best corrected visual acuity
was of 20/40 (right eye) and 20/125 (left eye) with contact
lenses. On slit-lamp biomicroscopy there was definite kerato-
conus; there were no other anterior segment abnormalities and
the endothelium was normal. The minimal corneal thickness
over the apex of the cone was 488 lm (right eye) and 448 lm
(left eye). Keratometry measurements were 49.3/46.6 D (right
eye) and 51.7/49.8 D in the left eye. Corneal topography
confirmed keratoconus (Fig. 3A). The patient underwent a
deep anterior lamellar keratoplasty in the left eye at the age of
40 years. The patient had a 37-year-old sister affected with
bilateral keratoconus (individual II:2, Fig. 2A) who carried the
same mutation. She was diagnosed with keratoconus at age 19
and underwent bilateral corneal transplantation at age 28 (right
eye) and 31 (left eye). Their father had normal corrected visual
acuities and corneal topography. Their mother was diagnosed
with Fuchs’ endothelial corneal dystrophy (FECD) at age 56.
FECD was diagnosed based on the presence of more than 5
mm confluent central corneal endothelial guttae in each eye
(Krachmer grade 4 or higher). She underwent bilateral cataract
surgery at age 58. At age 65, the patient had bilateral mild
corneal epithelial and stromal edema associated with increased
corneal thickness (Fig. 3B); central corneal thickness was 642
lm (right eye) and 618 lm (left eye). Her best corrected visual
acuity was 20/40 (right eye) and 20/125 (left eye). There was
no evidence of keratoconus clinically or on corneal topogra-
phy. The patient underwent bilateral Descemet’s stripping
automated endothelial keratoplasty at age 67. Segregation
analysis identified the variant in both affected (keratoconus)
siblings and the affected (FECD) mother, while it was absent in
the unaffected father as shown in Figure 2A.
RT-qPCR of Mutant ZEB1 (p.Gln640His) Cultured
Corneal Keratocytes
The expression of COL8A2 and the basement collagen genes
(COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, and COL4A6)
was evaluated by RT-qPCR in cultured corneal keratocytes
obtained from a patient harboring a missense mutation in
ZEB1 (c.1920G > T, p.Gln640His, Table 3). COL4A1 and
COL4A2 were markedly downregulated, and COL4A3, CO-
L4A4, and COL8A2 were moderately downregulated. The
expression level of ZEB1 was unchanged in the corneal
keratocytes harboring the ZEB1 mutation.
DISCUSSION
ZEB1 encodes the two-handed zinc-finger homeodomain
transcription factor, which can act as either a transcriptional
enhancer or repressor.32 Mutations in ZEB1 have been
reported in posterior polymorphous corneal dystrophy
(PPCD3; MIM #609141) and Fuchs’ endothelial corneal
dystrophy (FECD6; MIM #613270), and herein we report a
missense mutation in ZEB1 associated with keratoconus and
highlight a genotype–phenotype correlation. Missense substi-
tutions in the ZEB1 protein are associated with FECD6 and
keratoconus, whereas protein truncating mutations result in
PPCD3 (Fig. 4, Supplementary Table S3). Genotype-phenotype
correlations also exist in TGFBI (MIM *601692) associated
corneal dystrophies where specific missense mutations associ-
ated with arginine at codon 124 and 555 result in different
phenotypic manifestations.33,34
The largest published series reported ZEB1 mutations in
25% of patients with PPCD (8/32 probands)11 and the
prevalence of mutations in ZEB1 in PPCD has varied from
9.1% to 45.4%.5,9–11 In our study ZEB1 mutations were
detected in 11.1% (2/18 probands) with PPCD. The majority
of mutations were reported in exon 7, which most likely
represents the relative size of this exon consisting of 1811 bps
or 54% of the total ZEB1 transcript (3375 bps). All reported
ZEB1 mutations have been unique, although the methionine at
codon 1 mutation results from two different nucleotide
substitutions; c.1A > G (p.Met1Val)10 and c.2T > G
(p.Met1Arg).11 Although p.Met1Val and p.Met1Arg mutations
are missense, it is predicted that they would result in a
truncation of the ZEB1 protein as the initiation of translation
codon is disrupted.10 All ZEB1 mutations reported in PPCD3
are nonsense, frameshift, and missense, which result in protein
truncation.5,6,9–11 The proposed pathogenic mechanisms are
haploinsufficiency either due to nonsense medicated decay or
TABLE 3. RT-qPCR of the Relative Expression Level of ZEB1
Transcriptional Target Genes in Cultured Corneal Keratocytes Harbor-
ing the ZEB1 Mutation p.Gln640His
Gene PPIA HPRT1 RBL5 UBC GAPDH Average
COL4A1 0.01 0.01 0.02 0.02 0.02 0.01
COL4A2 0.03 0.01 0.03 0.03 0.04 0.02
COL4A3 0.17 0.09 0.2 0.2 0.2 0.17
COL4A4 0.2 0.1 0.3 0.3 0.3 0.24
COL4A5 1 0.5 1.3 0.8 1.4 1
COL4A6 0.8 0.4 0.9 1.2 1 0.86
COL8A2 0.5 0.2 0.5 0.3 0.7 0.44
ZEB1 0.9 0.7 1.4 0.8 1.5 1.06
All mRNA levels were measured at CT threshold levels and were
normalized with five reference genes; PPIA, HPRT1, RPL5, UBC, and
GAPDH CT values. Values were expressed as fold increase over the
corresponding values for control by the 2-DDCT method.
FIGURE 4. ZEB1 wild-type domain structure and locations of all known mutations to date. Mutations identified in PPCD patients are annotated
above the gene, and mutations identified in FECD and keratoconus patients are annotated below the gene. ZF, zinc finger; HD, homeodomain; RD,
repression domain; AD, activation domain.
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loss of functional domains due to truncations in the ZEB1
protein, or dominant-negative effects from the truncated
mutant ZEB1 protein.5
Liskova et al. failed to detect an association of keratoconus
and ZEB1 mutations in their PPCD3 cohort.4 Three PPCD3
patients had high keratometry readings representing corneal
steepening and increased corneal refractive power (corneal
power > 49 D), and no corneal thinning or other signs of
kerataconus.4 In our study, the keratoconus patients harboring
a pathogenic missense ZEB1 mutation did not have evidence of
PPCD3 and had characteristic features of keratoconus,
including typical corneal topography. Missense mutations in
ZEB1 have been reported in Fuchs’ endothelial dystrophy
(FECD6),14,15 although only identified in 2% (7/384) of cases in
the largest published series.14 Genetic variation in the
transcription factor 4 gene (TCF4; MIM602272) has been
associated with the development of FECD, in a potential
mechanism involving altered ZEB1 expression.35
We detected a pathogenic missense mutation in ZEB1
associated with keratoconus and FECD segregating in a family
suggesting common pathophysiologic mechanisms. The dys-
regulation of a-type IV collagens represents a common link
between ZEB1 mutation and the clinical phenotypes (PPCD3,
FECD, and keratoconus). Mutations in type IV collagens
(COL4A3, COL4A4, and COL4A5) cause Alport syndrome, a
triad of nephropathy, sensorineural deafness, and eye features
that include anterior lenticonus, PPCD, and keratoconus.36
Ectopic COL4A3 protein has been demonstrated in the corneal
endothelium of an individual with PPCD3 resulting from a
truncating mutation in ZEB1, and the expression of COL4A3 is
increased in the corneal endothelium of Zeb1-null mice.37 The
COL4A3 promoter contains a complex promoter binding site,5
and there is functional evidence that ZEB1 interacts with these
proximal and distal E2-box motifs to regulate COL4A3
expression.38 Altered ZEB1-mediated COL4A3 transcriptional
repression resulting from truncating mutations is proposed to
result in PPCD3.38 In the corneal endothelium of a patient with
PPCD3 resulting from a ZEB1 truncating mutation, qPCR
demonstrated ZEB1 expression was reduced whereas COL4A3
expression was 4- to 5-fold higher than in the normal corneal
endothelium.38 However, the actual site of the truncating
ZEB1 mutation and the impact on ZEB1 protein structure was
not reported.38 In our study, a missense mutation
(p.Gln640His) in the homeodomain of ZEB1 resulted in a
downregulation in a-type IV collagens, whereas the expression
of ZEB1 mRNA was unaltered.
ZEB1 core and secondary binding sites have been reported
in the promoter sites of COL8A2 and the basement collagen
genes (COL4A1, COL4A2, COL4A3, COL4A5, and COL4A6),
with only the COL4A3 promoter containing a complex site
consisting of the core and proximal downstream secondary
sequence.5 Given these findings, and that alterations in a-type
IV collagen have been implicated in PPCD537,38 and corneal
disease,36,39,40 we assessed the gene expression of COL8A2
and the basement collagen genes (COL4A1, COL4A2, COL4A3,
COL4A4, COL4A5, and COL4A6) by RT-qPCR in cultured
corneal keratocytes obtained from a patient harboring a
missense mutation in ZEB1 (c.1920G > T; p.Gln640His).
COL4A1, COL4A2, and COL4A3 expression were markedly
reduced in corneal keratocytes harboring a missense ZEB1
mutation (p.Gln640His).
Reduced expression of COL4A1 and COL4A3 has been
reported in keratoconus.39,40 Sequencing COL4A3 and CO-
L4A4 in 104 unrelated Slovenian patients with keratoconus did
not detect mutations, although there were significant differ-
ences in the genotypes of seven previously reported polymor-
phisms in COL4A3 and COL4A4 between keratoconic patients
and controls.41 COL4A1 mutations result in a variety of ocular
defects, including abnormalities in the cornea and anterior
segment.42,43 Mutational screening of COL4A1 in 15 Ecuador-
ian keratoconus families failed to detect pathogenic variants.44
Given the significant disruption in COL4A1 expression
detected in our study and previously in keratoconus,39 further
work is required to determine the role of COL4A1 in
keratoconus. We detected a reduction in COL8A2 expression
in corneal keratocytes harboring a missense ZEB1 mutation
(p.Gln640His). Disruption of COL8A1 and COL8A2 in a
knockout mouse model resulted in corneal thinning: kerato-
globus.45 Missense mutations in COL8A2 result in PPCD and
FECD8, although no pathologic variants have been reported in
keratoconus.46
The findings reported herein and in the literature support the
proposal that missense substitutions in the ZEB1 protein are
associated with FECD6 and keratoconus, whereas protein
truncating mutations result in PPCD3. We propose that the
functional impact of the class of mutation on ZEB1 alters
downstream gene expression and this forms the basis of the
genotype–phenotype correlation. The identification and char-
acterization of the molecular pathways regulated by ZEB1 in the
cornea and the functional impact of mutations on these
pathways is required to understand fully the observed geno-
type–phenotype correlations. Keratoconus and FECD result in
significant ocular morbidity and are major indications for corneal
transplantation.47 Dissecting the role of ZEB1 in the pathogen-
esis of inherited corneal dystrophies will provide important
insights into maintenance of corneal shape and clarity.
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